Endocannabinoid system modulation for visceral abdominal pain in inflammatory bowel disease and irritable bowel syndrome: A protocol for systematic review and meta-analysis [version 2; peer review: 2 approved]
Visceral Pain is a common debilitating symptom of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). The endocannabinoid system (ECS) is a prime target for alleviation of visceral pain, given its important role in both gastrointestinal physiology and pain. We will conduct a systema...
Saved in:
| Main Authors: | Rebecca M. Lane, Declan P. McKernan, Siobhain M. O'Mahony, Laurence J. Egan, David P. Finn, Brian E. McGuire |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2025-07-01
|
| Series: | HRB Open Research |
| Subjects: | |
| Online Access: | https://hrbopenresearch.org/articles/8-40/v2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Isolation and Identification of the Types of Bacteria that Cause Irritable Bowel Syndrome
by: Noor Mahmood Sultan, et al.
Published: (2025-01-01) -
Inflammatory Bowel Diseases and Irritable Bowel Syndrome: Overlap of Two Nosological Forms or Two Variants of the Same Disease?
by: A. A. Sheptulin, et al.
Published: (2019-12-01) -
Sexual function, depression, and quality of life in patients with irritable bowel syndrome
by: Amir Keshavarzi, et al.
Published: (2025-07-01) -
Increase in circulating GLP-1 following low FODMAP diet in irritable bowel syndrome patients
by: Umael Khan, et al.
Published: (2025-08-01) -
Acute effects of butyrate on intestinal permeability in patients with irritable bowel syndrome assessed by a novel colonoscopy research model
by: Mathias W. Scharf, et al.
Published: (2025-12-01)